Key result
Synthetic ANP significantly blunts ACTH-stimulated aldosterone secretion by shifting its dose-response curve.
Why the study?
Previous studies showed ANP inhibits aldosterone secretion stimulated by various factors, but the specific effect of ANP on ACTH-stimulated aldosterone secretion needed further investigation.
Answers are grounded in this paper and cite their sources.
In vitro ANP-aldosterone data should not change practice; hypothesis-generating for in vivo and clinical studies.
Previous studies have shown that atrial natriuretic peptide (ANP) inhibits the secretion of aldosterone by isolated adrenal glomerulosa cells stimulated by angiotensin II, ACTH and potassium in vitro and by angiotensin II in conscious unrestrained rats. In this study we investigated further the effects of synthetic ANP on the dose-response curve of aldosterone secretion stimulated by ACTH in vitro. ANP displaced the dose-response curve of aldosterone to ACTH to the right with a significant change in EC50. A similar effect of ANP was reproduced in vivo in conscious unrestrained rats. There was no significant effect of ANP on the corticosterone response to ACTH in vivo. ANP is a potent regulator of aldosterone secretion which may modulate the effects of ACTH on the adrenal in vitro and in vivo.
No takes yet. Share an insight, caveat, or question.
Chartier et al. (1986) studied this question. Synthetic atrial natriuretic peptide (ANP) vs. ACTH alone was evaluated on Aldosterone secretion stimulated by ACTH. Synthetic atrial natriuretic peptide displaced the dose-response curve of aldosterone to ACTH to the right with a significant change in EC50 in vitro and in vivo in conscious unrestrained rats.
Synapse has enriched 10 related papers. Consider them for comparative context: